Skip to main content
HERON THERAPEUTICS, INC. /DE/ logo

HERON THERAPEUTICS, INC. /DE/ — Investor Relations & Filings

Ticker · HRTX ISIN · US4277461020 LEI · 549300DR2I1DOPD2IX53 US Manufacturing
Filings indexed 1,030 across all filing types
Latest filing 2024-11-08 Major Shareholding Noti…
Country US United States of America
Listing US HRTX

About HERON THERAPEUTICS, INC. /DE/

https://www.herontx.com/

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on developing and commercializing therapies to address unmet medical needs in acute care and oncology. The company utilizes its proprietary drug delivery technologies to create novel, best-in-class treatments. Its product portfolio is designed to improve the lives of patients by providing solutions for significant medical issues, including postoperative pain management, with an aim to reduce opioid reliance, as well as managing postoperative and chemotherapy-induced nausea and vomiting.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2024
Major Shareholding Notification
2024-11-08 English
4
Director's Dealing
2024-11-06 English
3
Director's Dealing
2024-11-05 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated November 4, 2024, by Heron Therapeutics, Inc. The key content is the appointment of a new director to the Board of Directors, Michael Kaseta, with details about his term and compensation. The document also includes a press release as an exhibit related to this appointment. There is no financial data or report content; rather, it is an announcement of a change in the company's board. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is just over 5,000 characters but the content clearly matches a management change announcement, not a financial report or other category. Therefore, the correct classification is MANG with high confidence.
2024-11-04 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-10-24 English
4
Director's Dealing
2024-10-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.